An efficient, green, and reusable system comprising gold nanoparticles entrapped in an organically modified sol–gel silica matrix was found to catalyze the reduction of monobromo‐ and tribromoacetic acid by NaBH4. Interestingly, the reduction of tribromoacetic acid yielded succinic acid along with acetic acid, whereas monobromoacetic acid was reduced only to acetic acid. The relative yields of succinic acid and acetic acid depended on the rate of addition of BH4–. Slow addition resulted in the formation of succinic acid as the major product. A variable product distribution was achieved as a result of the different pathways for dehalogenation.
The efficient reductive dechlorination, as remediation of dichloroacetamide and monochloroacetamide, toxic and abundant pollutants, using sodium borohydride catalyzed by zero valent iron nanoparticles (ZVI-NPs), entrapped in organically modified hybrid silica matrices prepared via the sol-gel route, ZVI@ORMOSIL, is demonstrated. The results indicate that the extent of the dechlorination reaction depends on the nature of the substrate and on the reaction medium. By varying the amount of catalyst or reductant in the reaction it was possible to obtain conditions for full dechlorination of these pollutants to nontoxic acetamide and acetic acid. A plausible mechanism of the catalytic process is discussed. The present work expands the scope of ZVI-NP catalyzed reduction of polluting compounds, first reports the catalytic parameters of chloroacetamide reduction, and offers additional insight into the heterogeneous catalyst structure of M0@ORMOSIL sol-gel. The ZVI@ORMOSIL catalyst is ferromagnetic and hence can be recycled easily.
An innovative catalyst is reported for removing suspect carcinogen trichloroacetic acid (TCA) found in water after chlorination. SilverSil, a methyl-modified silica xerogel doped with Ag nanoparticles, shows remarkably high and stable activity as heterogeneous catalyst for the reductive dehalogenation of TCA with NaBH4 as reducing agent. Chloroacetic acid and acetic acid are the main products of the highly reproducible reductive dehalogenation. The low cost, high stability and ease of application of the SilverSil sol-gel catalyst to continuous processes open the route to the industrial uptake of SilverSil to free chlorinated waters from a probable human carcinogenic agent exerting significant genotoxic and cytotoxic effects.
Reduction of nitrobenzene with NaBH4 using zero-valent iron nanoparticles (ZVI-NPs) and NiCl2∙6H2O incorporated in organically modified hybrid silica matrices as ZVI@ORMOSIL and Ni(II)@ORMOSIL catalysts is proposed as a remediation strategy. Ni(II)@ORMOSIL is prepared by ion-exchanging H+ of the ORMOSIL matrix with NiII. Ni(II)@ORMOSIL is a pre-catalyst that undergoes reduction by NaBH4 by an in-situ reaction and promotes nitrobenzene reduction by the unconsumed NaBH4, leading to sparing use of the catalyst. Ni(II)@ORMOSIL undergoes color change from green to black in this process, returning to a green hue after washing and drying. Nitrobenzene reductions were examined in aqueous acetonitrile solvent mixtures, and the reduction cascade produced the reaction end-products with catalytic implications. Plausible mechanisms of ZVI@ORMOSIL and Ni(II)@ORMOSIL catalyzed reductions of nitrobenzene are discussed. This work is the first to report M(II)@ORMOSIL pre-catalysts for in-situ reduction of nitrobenzene, and expands the scope of the ORMOSIL series of catalysts for the reduction of polluting compounds. This approach enables the development of catalysts that use very low concentrations of transition metal cations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.